1 Université de Strasbourg, Centre Européen d'Etude du Diabète, Strasbourg, France.
2 Service de Chirurgie Plastique et Maxillo-faciale, Hôpitaux Universitaires de Strasbourg, Strasbourg Cedex, France.
Cell Transplant. 2018 Aug;27(8):1289-1293. doi: 10.1177/0963689718784873. Epub 2018 Jul 11.
Following the tremendous development of hydrogels for cell therapy, there is now a growing need for surgical techniques to validate in vivo scaffold benefits for islet transplantation. Therefore, we propose a newly designed surgical procedure involving the injection of hydrogel-embedded pancreatic islets in the omentum, which is considered a favorable environment for cell survival and function. Our technique, called h-Omental Matrix Islet filliNG (hOMING) was designed to test the benefits of hydrogel on islet survival and function in vivo. Islets were implanted in the omentum of diabetic rats using the hOMING technique and alginate as an islet carrier. Blood glucose and C-peptide levels were recorded to assess graft function. After 2 months, grafts were explanted and studied using insulin and vessel staining. All rats that underwent hOMING exhibited graft function characterized by a glycemia decrease and a C-peptidemia increase ( P < 0.001 compared with preoperative levels). Furthermore, hOMING appeared to preserve islet morphology and insulin content and allowed the proper revascularization of grafted islets. The results suggest that hOMING is a viable and promising approach to test in vivo the benefits of hydrogel administration for islet transplantation into the omental tissue.
随着水凝胶在细胞治疗方面的巨大发展,现在越来越需要手术技术来验证支架在胰岛移植中的体内益处。因此,我们提出了一种新设计的手术程序,涉及将水凝胶包埋的胰岛注射到网膜中,网膜被认为是细胞存活和功能的有利环境。我们的技术称为 h-Omental Matrix Islet filliNG(hOMING),旨在测试水凝胶对体内胰岛存活和功能的益处。使用 hOMING 技术和藻酸盐作为胰岛载体将胰岛植入糖尿病大鼠的网膜中。记录血糖和 C 肽水平以评估移植物功能。2 个月后,取出移植物并使用胰岛素和血管染色进行研究。所有接受 hOMING 的大鼠均表现出移植物功能,表现为血糖降低和 C 肽血症升高(与术前水平相比, P < 0.001)。此外,hOMING 似乎可以保持胰岛形态和胰岛素含量,并允许适当的血管化。结果表明,hOMING 是一种可行且有前途的方法,可以在体内测试水凝胶给药对胰岛移植到网膜组织中的益处。